For decades, the diagnosis of multiple myeloma required evidence of end-organ damage characterized by myeloma-defining events (MDEs) known as CRAB: Diagnosis also required -- and still does -- the ...

Kidney dysfunction: In multiple myeloma, proteins known as free light chains build up in the kidneys, causing impaired function or "renal insufficiency." Signs include changes in urine frequency ...

Nutrition plays a vital role in cancer prevention, treatment, and recovery, with plant-based diets offering significant ...

Four healthcare dividend stocks with significant upside potential and safe dividends look like outstanding investing ideas ...

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at ...

Johnson & Johnson (JNJ) reported upbeat Q1 results amid an exciting earnings season, with analysts noting impressive sales ...

A multi-institutional team developed a chimeric antigen receptor (CAR) T cell-based strategy for specifically targeting AML cells in patients who relapsed following other treatments. The team ...

While the condition has no cure, the focus is on prolonging her life so that she can live with the cancer. Now her two ...

Y-mAbs' naxitamab shows promise in treating high-risk neuroblastoma. Explore its phase 2 success, strong cash runway, and ...

In Canada, investors are getting results from Groupe Dynamite Inc. On Wall Street, markets are watching earnings from Bank of ...

First launched in 2015, Darzalex is already available across a range of multiple myeloma indications ... and shows no signs of slowing down, growing another 49% to reach $937 million in the ...

In multiple myeloma, these plasma cells become cancerous, multiplying uncontrollably and interfering with the normal function of the bone marrow and immune system. Although it is a complex disease ...